Articles On Avita Medical (ASX:AVH)

02 Jun 2020 - AVITA Medical (ASX:AVH) has submitted an Investigational Device Exemption (IDE) supplement with the US Food and Drug Administration (FDA) for a clinical trial to inve…

Around 12 months ago, we noted that Avita Medical (AVH) – which provides a novel approach to skin regeneration – was a business worth keeping tabs on.  Although its share price has felt the effects of the COVID-19 market sell-off, our posit...

Last year was a solid year for many ASX stocks and 2020 was also looking pretty good until COVID-19 struck the markets in late February. Earlier this week Reuben Adams recapped which of last year’s top mining and exploration companies have...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

The S&P/ASX 200 Index (ASX: XJO) ended the day up 0.35% to 5,422 points. The ASX 200 was down over 1% earlier in the day. China and Australia’s dispute continues to grow. The Asian superpower reminded Australia how important it is to t...

The S&P/ASX 200 Index (ASX: XJO) was back on form in April and had its best month in decades. Over the period the benchmark index recorded a gain of 8.8%. Not all shares were able to follow the market higher last month. Here’s why thes...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Avita Medical Ltd (ASX: AVH) shares are down 2.17% in morning trade, despite the ASX healthcare company reporting strong third quarter results today.  Avita Medical reported total product sales of $5.9 million during the March quarter, up...

The S&P/ASX 200 Index (ASX: XJO) is on course to record a very strong gain on Wednesday. In late morning trade the benchmark index is up 1.2% to 5,376.4 points. Four shares that have failed to follow the market higher today are listed...

With the Avita Medical Ltd (ASX:AVH) share price sitting at 45 cents at time of writing, let’s take a quick look at this stock that lit up the ASX prior to the onset of the coronavirus. Avita recently announced a plan to relocate from Austr...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and dropped lower. At the time of writing the benchmark index is down 1.3% to 5,157.9 points. Four shares that are not letting that hold them...

Noxopharm (ASX:NOX) is the latest biotech to announce it will test its drug against COVID-19. So how exactly does an anti-prostate cancer drug work for COVID-19? Noxopharm says it is all about one signalling pathway — the STING (Stimulator...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced its intention to redomicile from Australia to the US.

With the S&P/ASX 200 down as much as 130 points on Wednesday morning and a large percentage of Monday’s substantial rebound now lost, it may pay to scour the market for pockets of value. While also succumbing to the downturn in the broa...

With the S&P/ASX 200 down as much as 130 points on Wednesday morning and a large percentage of Monday’s substantial rebound now lost, it may pay to scour the market for pockets of value. While also succumbing to the downturn in the broa...

Alcidion’s (ASX:ALC) market cap may suggest it’s still a small cap, but it has come a long way from its founding and reverse IPO in 2016. The company is now larger than all 11 other ASX medtechs it listed in its investor presentation as com...

The healthcare sector has been one of the top-performing ASX industry sectors during the coronavirus crisis. This is only likely to continue over the next 6 months due to a high and continuing demand for a range of healthcare products and...

ASX shares are trading at deep discounts from previous highs thanks to the coronavirus pandemic. This gives investors the chance to swoop in on some bargains. So, let’s take a look at 5 ASX shares to buy across the technology and healthca...

The Ramsay Health Care Limited (ASX: RHC) share price is back on form on Thursday. On Wednesday Ramsay’s shares fell heavily after the government announced that it would soon stop elective surgeries. But in afternoon trade the private hosp...

Yesterday I highlighted a number of factors that could be seen as justification for investing in more speculative stocks in the current environment. Though seemingly counter-intuitive given the broader flight from equities to safe havens su...

In just two years, skin regenerator Avita Medical (ASX:AVH) has shot up from 6c to 40c and was granted entry into the ASX 200, but the company says it hasn’t made it yet. Chief financial officer David McIntyre, who joined Avita in November...

The ASX healthcare sector continues to be one of the top performers on the ASX in terms of share price rises. While most Australians are likely familiar with Cochlear Limited (ASX: COH), CSL Limited (ASX: CSL), and Ramsay Health Care Limit...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Australian investors enter the weekend with the ASX 200 (INDEXASX: XJO) falling over 2% on the final day of the week. How much did the ASX 200 fall over this week? Well it finished down 2.8% today to 6,216, which was a fall of 3.5% during...

The S&P/ASX 200 index has given back yesterday’s gains and more. In afternoon trade the benchmark index is down 1.8% to 6,281.3 points. Four shares that have fallen more than most today are listed below. Here’s why they are tumbling lo...

Shares in ASX 200 healthcare group Avita Medical Ltd (ASX: AVH) have had an impressive run in the last 12 months. In the past year, the medical tech group’s shares are up 353.57% higher to $0.64 per share. That means Avita’s market capital...

Regenerative medicine company Avita Medical (ASX: AVH) has commenced what it calls a “pivotal trial” for the treatment of paediatric scald injuries, seeking to demonstrate that its RECELL treatment can safely and effectively increase the in...

The S&P/ASX 200 index has followed the lead of U.S. markets and is charging higher on Thursday. At the time of writing the benchmark index is up 1.5% to 6,423.1 points. Four shares that are climbing more than most today are listed belo...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced the initiation of a trial for the treatment of paediatric scald injuries with an enrollment of the first patient in the US.

In morning trade the AVITA Medical Ltd (ASX: AVH) share price has been storming higher. At the time of writing the regenerative medicine company’s shares are up 7% to 66.5 cents. Why is the AVITA Medical share price storming higher? As wel...

In early afternoon trade the S&P/ASX 200 index is trading notably lower. At the time of writing the benchmark index is down 1.2% to 6,357.2 points. Four shares that have not let that hold them back are listed below. Here’s why they are...

Bone healing biotech company Osteopore (ASX: OSX) has posted strong revenue growth since its ASX debut, eyeing China and the US as the next markets for its regenerative technology. The Australian and Singapore-based business listed on the...

Whilst today’s market selloff is disappointing, it is worth remembering that even after today’s sea of red, the share market is still up significantly over the last 12 months. For example, since this time last year, the S&P/ASX 200 ind...

By Michael Gable  Despite the coronavirus, the US share market has made another all-time high, and the Australian market has been consolidating the gains from early January in an orderly fashion. Materials and Energy stocks remain a bit ris...

While the S&P/ASX 200 Index (INDEXASX: XJO) ended the day slightly down, here are 3 ASX shares that have shown strong upward share price movement today. AVITA Medical Ltd (ASX: AVH) After rocketing as much as 7.5% in mid-afternoon tr...

Spray-on-skin maker Avita has had runaway success on the ASX. And it's not done yet, says Morningstar's Nicolette Quinn.

The Polynovo Ltd (ASX: PNV) share price has been on a tear this year, up more than 56% so far. In December, sales of the company’s NovoSorb BTM product cracked $2 million for the first time, a 134% increase over the previous December. Nov...

By Greg Peel Second Leg Wall Street had used the excuse of solid earnings results and a better than expected GDP performance to turn around an initial fall on Thursday night into a rally on the close. Traders were not letting coronavi...

In afternoon trade the S&P/ASX 200 index is on course to finish the week on a positive note:. At the time of writing the benchmark index is up 0.3% to 7,031.1 points. Four shares that have climbed more than most today are listed below....

The AVITA Medical Ltd (ASX: AVH) share price has been a strong performer on Friday. In afternoon trade the global regenerative medicine company’s shares are up 6.5% to 68.2 cents. This makes AVITA the second-best performer on the ASX 200 i...

A choppy week looked set to end with an uplift as the share market recouped yesterday’s losses following a late reversal on Wall Street. The ASX 200 bounced 17 points or 0.2 per cent to 7025 this morning, but remained on track for its fi...

The GUD Holdings Limited (ASX: GUD) share price is on course to end the week on a positive note. In afternoon trade the diversified products company’s shares are up 6% to $11.87. This makes it the third-best performer on the ASX 200 index...

The Australian market lost yesterday’s gains as the number of reported coronavirus cases nears 8000 and impacts Asian markets. Despite morning gains, the ASX 200 trailed off just over an hour into the session. The benchmark index relin...

AVITA Medical (ASX:AVH) has announced that the US FDA has approved its application to conduct a feasibility study evaluating the safety and effectiveness of the RECELL Autologous Cell Harvesting Device for repigmentation of depigmen...

Investment site MarketIndex regularly aggregates the ratings of analysts from different brokerages to provide a market consensus on ASX shares. This consensus can be used to uncover ASX shares that warrant further investigation. Here are...

The PolyNovo Ltd (ASX: PNV) share price closed yesterday’s trading session more than 8% higher. Although there was no direct catalyst to prompt the share price move, it could be an indication of continued interest in the company. What does...

In 2019 the culmination of decades worth of work turned several biotechs and life sciences companies into overnight successes. As investors look to defensive growth stocks to compensate for a sluggish economy and with expectations of more h...

It was a great year for ASX healthcare shares in 2019, with the S&P/ASX Healthcare Index increasing by 41%. These 3 ASX healthcare shares experienced even greater gains in 2019, but can they continue to outperform in 2020?  Avita Med...

In 2019, the S&P/ASX 200 (INDEXASX: XJO) increased nearly 22%. Avita Medical Ltd (ASX: AVH) was the star performer on the index, up more than 700% for the year. Polynovo Ltd (ASX: PNV), EML Payments Ltd (ASX: EML), and Fortescue Metals...

The S&P/ASX 200 index was in fine form in 2019, ending the year with a return of just over 20% excluding dividends. Whilst the majority of shares on the index raced higher, a number climbed more than most. Here’s why these were the bes...